Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001325812-14-000001
Filing Date
2014-01-02
Accepted
2014-01-02 17:36:40
Documents
1
Period of Report
2013-12-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 7865
  Complete submission text file 0001325812-14-000001.txt   9244
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address
Reid Laurence (Reporting) CIK: 0001492749 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50743 | Film No.: 14502831